GB9110532D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9110532D0
GB9110532D0 GB919110532A GB9110532A GB9110532D0 GB 9110532 D0 GB9110532 D0 GB 9110532D0 GB 919110532 A GB919110532 A GB 919110532A GB 9110532 A GB9110532 A GB 9110532A GB 9110532 D0 GB9110532 D0 GB 9110532D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919110532A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GB919110532A priority Critical patent/GB9110532D0/en
Publication of GB9110532D0 publication Critical patent/GB9110532D0/en
Priority to JP5500202A priority patent/JPH06507899A/ja
Priority to AU21561/92A priority patent/AU2156192A/en
Priority to NZ242734A priority patent/NZ242734A/en
Priority to US08/150,018 priority patent/US5447949A/en
Priority to MX9202262A priority patent/MX9202262A/es
Priority to PCT/US1992/004071 priority patent/WO1992020651A2/en
Priority to EP9292913103A priority patent/EP0585383A4/en
Priority to ZA923496A priority patent/ZA923496B/xx
Priority to PT100491A priority patent/PT100491A/pt
Priority to TW081103799A priority patent/TW211010B/zh
Priority to IE153992A priority patent/IE921539A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB919110532A 1991-05-15 1991-05-15 Chemical compounds Pending GB9110532D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB919110532A GB9110532D0 (en) 1991-05-15 1991-05-15 Chemical compounds
ZA923496A ZA923496B (en) 1991-05-15 1992-05-14 Chemical compounds
US08/150,018 US5447949A (en) 1991-05-15 1992-05-14 N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity
AU21561/92A AU2156192A (en) 1991-05-15 1992-05-14 Chemical compounds
NZ242734A NZ242734A (en) 1991-05-15 1992-05-14 Heterocyclic imidazole derivatives, preparation and medicaments thereof
JP5500202A JPH06507899A (ja) 1991-05-15 1992-05-14 化合物
MX9202262A MX9202262A (es) 1991-05-15 1992-05-14 Compuestos quimicos.
PCT/US1992/004071 WO1992020651A2 (en) 1991-05-15 1992-05-14 N-(heteroaryl)-imidazolyl-alkenoic acids
EP9292913103A EP0585383A4 (en) 1991-05-15 1992-05-14 Chemical compounds
PT100491A PT100491A (pt) 1991-05-15 1992-05-15 Acidos n-(heteroaril)-imidazolil-alcenoicos, composicoes farmaceuticas que os contem e seu uso
TW081103799A TW211010B (https=) 1991-05-15 1992-05-15
IE153992A IE921539A1 (en) 1991-05-15 1992-07-01 Chemical compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919110532A GB9110532D0 (en) 1991-05-15 1991-05-15 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9110532D0 true GB9110532D0 (en) 1991-07-03

Family

ID=10695047

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919110532A Pending GB9110532D0 (en) 1991-05-15 1991-05-15 Chemical compounds

Country Status (11)

Country Link
EP (1) EP0585383A4 (https=)
JP (1) JPH06507899A (https=)
AU (1) AU2156192A (https=)
GB (1) GB9110532D0 (https=)
IE (1) IE921539A1 (https=)
MX (1) MX9202262A (https=)
NZ (1) NZ242734A (https=)
PT (1) PT100491A (https=)
TW (1) TW211010B (https=)
WO (1) WO1992020651A2 (https=)
ZA (1) ZA923496B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
KR100587187B1 (ko) * 1997-10-29 2006-10-24 론자 아게 포르밀이미다졸의제조방법
KR100567183B1 (ko) * 1997-11-14 2006-06-13 론자 아게 포르밀이미다졸의제조방법
JP2000053651A (ja) * 1998-06-18 2000-02-22 Lonza Ag ホルミルイミダゾ―ル類の製造方法
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011500783A (ja) * 2007-10-22 2011-01-06 オーキッド リサーチ ラボラトリーズ リミテッド ヒストンデアセチラーゼ阻害剤
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0403159T3 (da) * 1989-06-14 2000-08-14 Smithkline Beecham Corp Imidazolylalkensyrer
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles

Also Published As

Publication number Publication date
AU2156192A (en) 1992-12-30
WO1992020651A3 (en) 1993-02-18
JPH06507899A (ja) 1994-09-08
IE921539A1 (en) 1992-11-18
MX9202262A (es) 1992-11-01
EP0585383A4 (en) 1994-08-17
PT100491A (pt) 1993-09-30
EP0585383A1 (en) 1994-03-09
NZ242734A (en) 1995-04-27
TW211010B (https=) 1993-08-11
ZA923496B (en) 1993-04-28
WO1992020651A2 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
AP9200385A0 (en) Chemical compounds
GB9109557D0 (en) Chemical compounds
GB9103862D0 (en) Chemical compounds
GB9105152D0 (en) Chemical compounds
GB9103770D0 (en) Chemical compounds
GB9110532D0 (en) Chemical compounds
GB9100431D0 (en) Chemical compounds
GB9109497D0 (en) Chemical compounds
GB9110623D0 (en) Chemical compounds
GB9110507D0 (en) Chemical compounds
GB9100637D0 (en) Chemical compounds
GB9106350D0 (en) Chemical compounds
GB9100628D0 (en) Chemical compounds
GB9104889D0 (en) Chemical compounds
GB9100433D0 (en) Chemical compounds
GB9100434D0 (en) Chemical compounds
GB9100435D0 (en) Chemical compounds
GB9100436D0 (en) Chemical compounds
GB9100438D0 (en) Chemical compounds
GB9110620D0 (en) Chemical compounds
GB9100441D0 (en) Chemical compounds
GB9100442D0 (en) Chemical compounds
GB9110619D0 (en) Chemical compounds
GB9100429D0 (en) Chemical compounds
GB9102188D0 (en) Chemical compounds